Trending...
- For Labor Day: Check out a poem about Labor and Manufacturing called "It used to be Made in America" - 210
- California prioritized fighting organized retail theft, those results are paying off with 36,000 arrests and $293 million in stolen goods recovered - 112
- California and the Australian state of Queensland ink new partnership to accelerate climate resilience, agricultural technology, and innovation - 109
WINDSOR, Ontario - Californer -- A market maker has filed a Form 211 Application with the Financial Industry Regulatory Authority ("FINRA") to request permission to quote and trade the securities of CEN Biotech, Inc. ("CEN Biotech" or the "Company") on OTC Markets. CEN Biotech is a Global Holding company focusing on Hemp (and it's legal derivatives), functional and innovative foods, nutrition, and cutting edge advancements in LED Lighting technology.
The Form 211 Application must be approved by FINRA in order to receive a ticker symbol and begin trading. CEN Biotech intends to submit an application to have its common stock quoted on OTC Markets as soon as practicable after the Form 211 Application is approved. However, there can be no assurance that FINRA will approve our Form 211 Application, and if it does approve it, there can be no assurance of the timing of such approval.
Forward-looking Statements
This press release may contain "forward-looking" statements. These forward-looking statements are only predictions and are subject to certain risks, uncertainties and assumptions that could cause actual results to differ from those in the forward looking-statements. Potential risks include such factors as the inability to enter into agreements with parties with whom we are in discussions, the uncertainty of consumer demand for the Company's products or services, as well as additional risks and uncertainties that are identified and described in the Company's reports filed with the Securities and Exchange Commission. Results may differ materially from the forward-looking statements in this press release. Statements made herein are as of the date of this release and should not be relied upon as of any subsequent date. The Company does not undertake, and it specifically disclaims, any obligation to update any forward-looking statements to reflect occurrences, developments, events or circumstances after the date of such statement.
More on The Californer
About CEN Biotech, Inc.
CEN Biotech, Inc. is a Global Holding company focusing on Hemp (and it's legal derivatives), functional and innovative foods and nutrition, and cutting edge advancements in LED Lighting technology. www.cenbiotechinc.com
Press Contact
Brian Payne, Vice President / Corporate Secretary - Direct: (519) 419-4958, Extension 1505 - E:Mail: brian@cenbiotechinc.com
The Form 211 Application must be approved by FINRA in order to receive a ticker symbol and begin trading. CEN Biotech intends to submit an application to have its common stock quoted on OTC Markets as soon as practicable after the Form 211 Application is approved. However, there can be no assurance that FINRA will approve our Form 211 Application, and if it does approve it, there can be no assurance of the timing of such approval.
Forward-looking Statements
This press release may contain "forward-looking" statements. These forward-looking statements are only predictions and are subject to certain risks, uncertainties and assumptions that could cause actual results to differ from those in the forward looking-statements. Potential risks include such factors as the inability to enter into agreements with parties with whom we are in discussions, the uncertainty of consumer demand for the Company's products or services, as well as additional risks and uncertainties that are identified and described in the Company's reports filed with the Securities and Exchange Commission. Results may differ materially from the forward-looking statements in this press release. Statements made herein are as of the date of this release and should not be relied upon as of any subsequent date. The Company does not undertake, and it specifically disclaims, any obligation to update any forward-looking statements to reflect occurrences, developments, events or circumstances after the date of such statement.
More on The Californer
- NITE-E-NIGHT: The Future of Gaming Is Live
- Long Beach to Launch Time Capsule Honoring America's 250th Anniversary as Part of 908 Day Celebration
- Long Beach Airport Celebrates Alaska Airlines' Twice-Daily Nonstop Flight Service to Seattle
- Vallejo Home Prices Are Down—So Why Are So Many Homes Still Selling Over Asking?
- Newport Harbor and Corona del Mar Set for Battle of the Bay Showdown at Davidson Field
About CEN Biotech, Inc.
CEN Biotech, Inc. is a Global Holding company focusing on Hemp (and it's legal derivatives), functional and innovative foods and nutrition, and cutting edge advancements in LED Lighting technology. www.cenbiotechinc.com
Press Contact
Brian Payne, Vice President / Corporate Secretary - Direct: (519) 419-4958, Extension 1505 - E:Mail: brian@cenbiotechinc.com
Source: CEN Biotech Inc.
0 Comments
Latest on The Californer
- Franchise Operators Are Standardizing Compliance Across Every Location in 2026
- Impact & Influence March 2026: Joel Rodriguez Tirado - Why You're Still Waiting & The Power of Start
- New Comparison Helps Senior Travelers Weigh Overseas Adventure Travel Against Road Scholar
- Heritage at Manalapan Welcomes New Sales Team as Luxury Single-Family Home Community Continues to Grow
- Applications Now Open for the 2027 BrightEdge Entrepreneurs Program
- Mandeville Pests May Pose Serious Health Risks for Your Family
- xBxBio Advances Connected Cardiovascular Intelligence With Chapter 2 Release
- Share your workplace safety solutions at 2027 Applied Ergonomics Conference
- Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89
- May The Worst Team Win! Loserball Kicks Off Another NFL Season of Hilarious Mayhem
- Wehb.pro Launches $99 AI Website Builder With No Subscription or Platform Lock-In
- Top 10 AI Trading Robots Beat Market targeting High-Margin Stocks at 155% Annualized Return for Retail Investors (NVDA, USAR)
- Black Women Living With, and Impacted by, HIV Express Gratitude, Grief, Joy, and Resilience
- MainConcept Easy Video API Extends Full Transcoding to Arm and NETINT VPUs
- Boost Board Gives Daily Visibility to Fundraising Campaigns Stuck at Zero
- Hazel-E Celebrates the Premiere of "Keeping Up With Hazel-E" on Wave TV Network
- Talaria E-bike China Source Cuts Talaria Sting MX5 Pro Pricing by $700
- Disruptor Creations Options Untitled Feature Film Written by David Krumholtz and Johnny Markows
- Skin Health Expert and Nurse Practitioner Blossom Inuenwi Launches 'The Glow Brief' Podcast
- AristoPup Grooming Launches "Fresh Start Grooming Days" to Help Palm Springs Animal Shelter Dogs
